New hires and promotions in the biopharma industry, including: Agile, Biosig, Clearside, Emergent, Imago, Moleculin, Morphosys, Rocket, Silverback, Therapeuticsmd, Trovagene.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Applied Therapeutics, Arcutis, Atyr, Cara, Catalyst, CSL Behring, Erytech, Hookipa, Idera, Novartis, Oncoimmune, Synexis.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Olix Pharmaceuticals.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: 4D Pharma, Algernon, Alphamab Oncology, Eagle, Everest Medicines, Humanigen, Hutchison China Meditech, Mayne Pharma, Mithra, Redhill, Remegen, Sinovac, SLA Pharma, The KD Pharma Group, Zai Lab.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Alexion, Ansun, Astrazeneca, Beigene, Biosig Technologies, Bristol Myers Squibb, Cytodyn, Exelixis, Healios, Incyte, Ipsen, Karyopharm, Novartis, Novavax, Roivant Sciences, Sinovac, Sunovion, Takeda, Viralclear.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 48Hour Discovery, 7 Hills, Afecta, AI Vivo, Aikido Pharma, Aligos, Anixa, Applied Biology, Applied Botanics, Applied DNA, Atomwise, Benitec, Biogen, Botanix, Cerespir, Chromadex, Clinigen, Cyclacel, Cynata, Dynavax, Eagle, Esperion, Fairjourney, Fujifilm, Fusion Antibodies, Generex, Ginkgo Bioworks, Halix, Hansoh, Iksuda, Immunitybio, Immutep, Inato, Inmune, Innocan, Inovio, Iontas, Khondrion, Kubota Vision, Legochem, Leo, Ligandal, Luxna, Moderna, Molecular Partners, Nantkwest, Nicox, Northern Data, Octapharma, Ontochem, Otsuka, Porton, Promis, Pulmatrix, Recce, Redhill, Retrotope, Roche, SAB, Samsung Bioepis, Sinovac, Soligenix, Som Biotech, Sosei, Starpharma, Takis Biotech, Transcelerate, Xenothera, Xylyx.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Athersys.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brainlab, Inspire Medical Systems, Labcorp, Roche.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advarra, Amc Health, Archerdx, Centogene, Cerus, Curetis, Evicore Healthcare, Karolinska Institutet, Kurin, Opgen, Oxford Immunotec, Premier, Science 37, Simplify Medical, Vizient.

Med-tech firms raising money in public or private financings, including: GE, Nemaura Medical.